According to WSJ just now, Genzyme expects to stop rationing its Fabrazyme during the 1st half of next year - which could still be up to 9 months from now by my calendar.
For the patients who are waiting on their meds to return to normal, I hope it is sooner rather than later.
The timing may be a little curious for this announcement since its not really effective until 2011 at the earliest. Would this have anything to do with positive PR at a time when the company is under acquisition rumors? Perhaps, a few kudos for current management?
Posted by Bruce Lehr September 15th 2010.
Comments